MARKET

BIIB

BIIB

Biogen Inc
NASDAQ
227.60
+1.24
+0.55%
After Hours: 227.60 0 0.00% 19:30 09/25 EDT
OPEN
228.27
PREV CLOSE
226.36
HIGH
228.92
LOW
223.76
VOLUME
958.03K
TURNOVER
--
52 WEEK HIGH
229.19
52 WEEK LOW
135.39
MARKET CAP
33.63B
P/E (TTM)
40.31
1D
5D
1M
3M
1Y
5Y
1D
Biogen (BIIB) Could Be 4% Undervalued After Strong Earnings And Product News
Simply Wall St · 1d ago
Analysts Conflicted on These Healthcare Names: Harmony Biosciences Holdings (HRMY), BioNTech SE (BNTX) and Biogen (BIIB)
TipRanks · 2d ago
CALF, EXPE, GDDY, BIIB: ETF Inflow Alert
NASDAQ · 5d ago
Learn Why The Bull Case For Biogen Stock Could Change Following At Home LEQEMBI Approval
Simply Wall St · 6d ago
Weekly Report: what happened at BIIB last week (0914-0918)?
Weekly Report · 6d ago
Weekly Buzz: RARE, BAYRY Win Approvals; SION Cuts Jobs, GSK Deals; AZN, RHHBY Lead
NASDAQ · 09/18 14:44
Trump administration is said to weigh allowing most pharma licensing deals with China
Seeking Alpha · 09/18 11:08
Analysts Offer Insights on Healthcare Companies: Neuronetics (STIM), Xenon (XENE) and Biogen (BIIB)
TipRanks · 09/18 10:50
More
About BIIB
Biogen Inc. is a biotechnology company. The Company is focused on discovering, developing and delivering therapies. It has a portfolio of medicines to treat Multiple Sclerosis (MS), has introduced an approved treatment for Spinal Muscular Atrophy (SMA), co-developed treatments to address a defining pathology of Alzheimer's disease and launched an approved treatment to target a genetic cause of Amyotrophic Lateral Sclerosis (ALS). It markets a drug approved in United States, European Union and certain international markets for the treatment of Friedreich Ataxia (FA) in adults and adolescents aged 16 years and older. It is focused on advancing its pipeline in neurology, specialized immunology and rare diseases. Its marketed products include VUMERITY, TYSABRI, TECFIDERA, AVONEX and PLEGRIDY for the treatment of MS; SPINRAZA for the treatment of SMA; SKYCLARYS for the treatment of FA, and QALSODY for the treatment of ALS. Its commercialized products also include EMPAVELI and SYFOVRE.

Webull offers Biogen Inc stock information, including NASDAQ: BIIB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIIB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIIB stock methods without spending real money on the virtual paper trading platform.